Get access
Clinical & Experimental Allergy

New concepts concerning the clinical control of IgE synthesis

Authors

  • DAVID H. KATZ

    Corresponding author
    1. Department of Cellular and Developmental Immunology, Scripps Clinic and Research Foundation, La Jolla, California U.S.A.
      Dr David H. Katz, Department of Cellular and Developmental Immunology, Scripps Clinic and Research Foundation, 10666 North Torrey Pines Road, La Jolla, CA 92037, U.S.A.
    Search for more papers by this author

Dr David H. Katz, Department of Cellular and Developmental Immunology, Scripps Clinic and Research Foundation, 10666 North Torrey Pines Road, La Jolla, CA 92037, U.S.A.

Summary

Prospects for new therapeutic approaches to IgE-mediated allergic diseases have arisen from (1) recent experimental observations that have suggested new concepts concerning the pathogenesis of the allergic phenotype, and (2) adaptation of previously-described methods for induction of specific immunological tolerance to problems in allergy. The bases for these new approaches to allergic diseases are summarized herein.

Get access to the full text of this article

Ancillary